(Q40379234)

20 September 2017

1 reference

title

Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome (English)

1 reference

20 September 2017

H W Moser

1

1 reference

20 September 2017

1 January 1995

1 reference

Journal of Inherited Metabolic Disease

20 September 2017

1 reference

20 September 2017

18

1 reference

20 September 2017

435-447

1 reference

20 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00710055

20 September 2017

0 references

cites work

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1007%2FBF00710055

Dietary erucic acid therapy for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00710055

Adrenoleukodystrophy. A clinical and pathological study of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00710055

Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00710055

Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids

21 January 2018

1 reference

12 December 2020

Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes

1 reference

12 December 2020

The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications

1 reference

12 December 2020

Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment.

1 reference

12 December 2020

A family of closely related ATP-binding subunits from prokaryotic and eukaryotic cells

1 reference

12 December 2020

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy

1 reference

12 December 2020

Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes

1 reference

12 December 2020

Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN)

1 reference

12 December 2020

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

1 reference

12 December 2020

Adrenomyeloneuropathy presenting as Addison's disease in childhood

1 reference

12 December 2020

Adrenoleukodystrophy: a scoring method for brain MR observations

1 reference

12 December 2020

Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells

1 reference

12 December 2020

Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels

1 reference

12 December 2020

Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.

1 reference

12 December 2020

Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy.

1 reference

12 December 2020

Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids

1 reference

12 December 2020

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).

1 reference

12 December 2020

Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy

1 reference

12 December 2020

Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.

1 reference

12 December 2020

Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil

1 reference

12 December 2020

Genomic organization of the adrenoleukodystrophy gene

1 reference

12 December 2020

The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy

1 reference

12 December 2020

The morbid anatomy of the demyelinative disease

1 reference

12 December 2020

Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency

1 reference

12 December 2020

Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts

1 reference

12 December 2020

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

1 reference

12 December 2020

Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation

1 reference

12 December 2020

A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.

1 reference

12 December 2020

Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro

1 reference

12 December 2020

Fatty acid abnormality in adrenoleukodystrophy

1 reference

12 December 2020

Adrenoleukodystrophy: phenotypic variability and implications for therapy

1 reference

12 December 2020

Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin

1 reference

12 December 2020

Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).

1 reference

12 December 2020

Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00710055

1 reference

PubMed ID

7494402

Dimensions Publication ID

20 September 2017

0 references

1 reference

PubMed ID

7494402